Trial · NCT04700176
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Objective Response Rate (Cohort A) | 12 Months | To determine the ORR of the combination of Dara + Pom + Dex + ATRA in patients progressing on Dara + Len + Dex (Cohort A) |
| Primary | Incidence of Adverse Events | 12 Months | Incidence of Adverse Events in the combination of Dara + Pom + Dex + ATRA using CTCAE V5 criteria. |
| Secondary | Objective Response Rate (Cohort B) | 12 Months | To determine the ORR of the combination of Dara + Pom + Dex + ATRA in patients progressing on Dara + Pom + Dex |
| Secondary | Rate of Stringent Complete Response | 12 Months | To determine the best stringent complete response (sCR)/CR/near CR (nCR) and \>/= very good partial response (VGPR) rates. |
| Secondary | Incidence of Treatment-Emergent Adverse Events | 12 Months | To define the toxicity using CTCAE V5 criteria. |
| Secondary | Rate of Minimal Residual Disease Evaluation | 12 Months | To evaluate the status of minimal residual disease (MRD) in patients who achieve sCR, CR, or nCR. |
| Secondary | Time on Study (TOS) | 12 Months | Duration from start of study treatment to end of study |
| Secondary | Duration of Response (DOR) | 12 Months | Duration from treatment response to progression |
| Secondary | Time To Progression (TTP) | 12 Months | Duration from start of study treatment to progression |
| Secondary | Progression-Free Survival (PFS) | 12 Months | Duration from start of study treatment to PD or death \[regardless of cause\], whichever comes first |
| Secondary | Overall Survival (OS) | 12 Months | Duration from start of study treatment to death |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04700176/registered